Alpha Tau Medical Ltd., (DRTS): Price and Financial Metrics
DRTS Price/Volume Stats
| Current price | $3.10 | 52-week high | $3.40 |
| Prev. close | $3.13 | 52-week low | $1.75 |
| Day low | $3.06 | Volume | 26,100 |
| Day high | $3.15 | Avg. volume | 33,809 |
| 50-day MA | $2.54 | Dividend yield | N/A |
| 200-day MA | $2.46 | Market Cap | 216.76M |
DRTS Stock Price Chart Interactive Chart >
Alpha Tau Medical Ltd., (DRTS) Company Bio
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
DRTS Price Returns
| 1-mo | 35.08% |
| 3-mo | 30.53% |
| 6-mo | 41.23% |
| 1-year | 3.33% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 2.99% |
| 2023 | -5.35% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...